For the record, other companies are having (early) success with RNA too. BioNTec...

		guruz on July 15, 2020 \| parent \| context \| favorite \| on: Moderna’s SARS-CoV-2 Vaccine Phase I Data For the record, other companies are having (early) success with RNA too. BioNTech https://investors.biontech.de/news-releases/news-release-det... CureVac https://www.curevac.com/news/curevac-s-optimized-mrna-platfo...